Cabergoline Tablet
Product Images NDC 0093-5420

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cabergoline (NDC 0093-5420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of cabergoline, showing its molecular framework with various rings, nitrogen atoms, and functional groups typical of its ergot derivative class.*

FDA Label Image

Image 2

The packaging label for Cabergoline Tablets USP 0.5 mg by Teva Pharmaceuticals USA, Inc. shows an 8-tablet unit-of-use package. The label includes the product name, strength, NDC number 0093-5420-88, and instructions to dispense in the original container. The design features blue and white colors with the Teva logo at the bottom.*

FDA Label Image

Image 3

Packaging label for Cabergoline Tablets USP 0.5 mg by Teva Pharmaceuticals USA, Inc. The label includes the NDC number 0093-5420-88, specifies 8 tablets per unit-of-use container, and states the active ingredient amount per tablet. Storage instructions and prescription-only status are noted. Manufactured in the Czech Republic for Teva Pharmaceuticals USA, North Wales, PA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.